BridgeMD
New treatment option for Immediate Implant Placement
Official title Evaluation of Doxycycline Nanoparticle With Gelatin Sponge on Immediate Implant in Esthetic Region
ClinicalTrials.gov ID: NCT06809829
What this study is testing
- What it's testing
- The goal of this clinical trial is to Evaluate the effect of Doxycycline nanoparticles along with gelatin sponge in immediate implant cases in esthetic zone. The main question it aims to answer is: Does the application of doxycycline nanoparticles with gelatin sponge improve the clinical and radiographic outcomes of immediate implant cases in esthetic zone?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- The presence of non-restorable single-rooted maxillary centrals, canines or premolars.
- Sufficient bone volume.
- Good oral hygiene.
- The remaining space between the socket and the fixture equals or more than 2mm at the coronal third of the socket.
- Sufficient bone width (≥ 1 mm) in the buccal plate of the remaining bone to place an implant confirmed by cone beam computer tomography (CBCT).
You likely can't join if
- Insufficient bone volume.
- Active infection.
- Patients on chemotherapy or radiotherapy.
- Patients who have systemic disorders {uncontrolled diabetes mellitus, autoimmune disease, …etc},
- Pregnant patients,
- Patients with bone diseases
See the full eligibility criteria
- The presence of non-restorable single-rooted maxillary centrals, canines or premolars.
- Sufficient bone volume.
- Good oral hygiene.
- The remaining space between the socket and the fixture equals or more than 2mm at the coronal third of the socket.
- Sufficient bone width (≥ 1 mm) in the buccal plate of the remaining bone to place an implant confirmed by cone beam computer tomography (CBCT).
- Insufficient bone volume.
- Active infection.
- Patients on chemotherapy or radiotherapy.
- Patients who have systemic disorders {uncontrolled diabetes mellitus, autoimmune disease, …etc},
- Pregnant patients,
- Patients with bone diseases
- Presence of periapical pathology affecting the neighbouring teeth.
- Smokers.
The study team makes the final eligibility decision.
Where it's taking place
- Kafrelsheikh, Kafrelsheikh, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kafrelsheikh, Kafrelsheikh, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.